
Sign up to save your podcasts
Or


Biotechnology and pharmaceutical companies are increasingly investing in the development for therapeutics for hearing disorders. In this episode, Dr. Brian Taylor sits down with Celia Belline, CEO of CILCare and Peter Markham, CEO of CBSET, to discuss the future of pharmaceuticals and regenerative medicine in the identification and treatment of hearing disorders.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
By This Week in Hearing5
11 ratings
Biotechnology and pharmaceutical companies are increasingly investing in the development for therapeutics for hearing disorders. In this episode, Dr. Brian Taylor sits down with Celia Belline, CEO of CILCare and Peter Markham, CEO of CBSET, to discuss the future of pharmaceuticals and regenerative medicine in the identification and treatment of hearing disorders.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing

7,613 Listeners

2,688 Listeners

112,426 Listeners

56,545 Listeners

1,327 Listeners

19 Listeners

15,948 Listeners

1,428 Listeners